https://investor.ironwoodpharma.com/press-releases/press-release-details/2019/Ironwood-Pharmaceuticals-Announces-Adjustment-of-Conversion-Rate-for-its-225-Convertible-Senior-Notes-due-2020/default.aspx
Ironwood Pharmaceuticals is a leading gastrointestinal (GI) healthcare company on a mission to advance the treatment of GI diseases and redefine the standard of care for GI patients.
- April 16, 2019